Hospital Universitario General De Villalba — Clinical Trial Site

9 Registered trials

6 Currently recruiting

Organisation

Hospital Universitario General De Villalba

Location

Collado Villalba, Spain

Identifier

ORG-100047675

Address

Carretera De Alpedrete A Moralzarzal M-608 Km 41, 28400, Spain

Departments

Allergy
Departamento de Psiquiatría
Pediatría
Psiquiatría
Psychiatry
Psychiatry service
Servicio de Psiquiatría
Urologia

Clinical trials at this site (9)

Search interface

Long Term Study of Ecopipam Tablets in Children, Adolescents and Adults with Tourette’s Disorder Recruiting

2023-503545-67-00 Tourette's Disorder 5 2024-04-30
Study to evaluate the comparative efficacy of LacTEST for the diagnosis of hypolactasia in children presenting symptoms of lactose intoleran… Recruiting

2025-521294-13-00 Lactose intolerance 6 2025-07-14
A study to measure how well seltorexant works in adult depressed patients and how safe it is both for short- and long-term use when taken wi… Recruiting

2023-509070-36-00 Major Depressive Disorder with Insomnia Symptoms 5 2025-03-18
clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontin… Recruiting

2024-514833-39-00 Stress or mixed urinary incontinence in women over 50 y 3 2024-12-16
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting

2023-507372-42-00 Schizophrenia 4 2021-09-20
Clinical trial to asses the efficacy and safety of a vaccine for grasses and cupressaceae allergy Recruiting

2024-514524-16-00 Aetiological treatment of moderate-severe intermitent o 5 2021-05-11
A Phase III study to investigate two initial administrations of COMP360 in treatment-resistant depression Ended

2023-505268-12-00 Treatment-resistant depression 5 2024-02-09
Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND) Ended

2023-503494-38-00 Tourette’s Disorder 5 2023-07-20
A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study Ended

2024-511560-93-00 Schizophrenia 5 2022-03-29